by Sue Thomas The Non-Oral Therapy Roadshows have been a great success this year raising awareness of the potential treatments and non-oral pathways for people with Parkinson’s (PwP) who might have more complex therapy needs. Around 10% of each Parkinson’s population may require one of the non-oral therapies, namely apomorphine, deep brain stimulation or duodopa. […]
by Dr Christopher Kobylecki Non-oral therapies for Parkinson’s disease comprise apomorphine infusion, deep brain stimulation (DBS) surgery, and levodopa-carbidopa intestinal gel (LCIG, Duodopa®). Whereas people with Parkinson’s disease typically respond consistently to oral medications for several years, motor fluctuations and levodopa-induced dyskinesia affect half of patients after 4-5 years (1). This heralds the “complex” phase […]
Today and tomorrow we will be at The Royal College of Physicians of Edinburgh for their two-day symposium, which will cover the management of motor and non-motor complications of Parkinson’s, updates on the latest scientific developments and the important role of multidisciplinary teams in caring for people with Parkinson’s.
The Parkinson’s Academy roadshows are touring the country again offering expert MasterClass training in one afternoon for busy healthcare professionals. Courses are available on the non-oral therapies for Parkinson’s and non-motor symptoms. Following its success in 2016, the Non-Oral Therapy Roadshow is back on the road. We have re-launched a new series of this regional roadshow which explores […]